Yong Wei1,2, Qianying Ji1, Wenren Zuo1, Shiyan Wang1, Xinyi Wang1, Qingyi Zhu1,2. 1. Department of Urology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. 2. Department of Urology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
We would like to thank Wei et al. (1) for their comments on our research (2): efficacy and safety of single-port robotic radical prostatectomy and multiport robotic radical prostatectomy: a systematic review and meta-analysis.The reviewers (Wei et al.) said that we stated that a total of seven comparative studies involving 1,711 patients were included in our study, but three of the studies were from the same medical center, which indicates that there is a high possibility of data duplication (3-5). In this situation, we should clearly indicate that the counting of the included population was 1,711 instead of population.Secondly, the reviewers said that we claimed that the seven included studies were all randomized controlled trials, but a closer reading of the original text revealed that most of the studies were retrospectively designed. After a careful screening of the included literature, we should correct this statement and specify whether the included articles were randomized controlled trials or retrospective studies.Thirdly, they suggested that we conduct a subgroups analysis based on the robot manufacturer. This is a constructive advice, and we could perform a subgroup analysis in the next study.The article’s supplementary files as
Authors: Louis Lenfant; Guilherme Sawczyn; Alireza Aminsharifi; Soodong Kim; Clark A Wilson; Alp T Beksac; Zeyad Schwen; Jihad Kaouk Journal: Eur Urol Focus Date: 2020-11-05